“Bimekizumab Efficacy and Safety Versus Adalimumab in Patients With Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE)”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s15. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1168.